PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectivesFabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia et al.|Expert Opinion on Drug Metabolism & Toxicology|2018Cited by 8